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ABSTRACT: The folding mechanisms of helical membrane proteins remain largely uncharted.
Here we characterize the kinetics of bacteriorhodopsin folding and employ φ-value analysis to
explore the folding transition state. First, we developed and confirmed a kinetic model that allowed
us to assess the rate of folding from SDS-denatured bacteriorhodopsin (bRU) and provides
accurate thermodynamic information even under influence of retinal hydrolysis. Next, we obtained
reliable φ-values for 16 mutants of bacteriorhodopsin with good coverage across the protein. Every
φ-value was less than 0.4, indicating the transition state is not uniquely structured. We suggest that
the transition state is a loosely organized ensemble of conformations.
■ INTRODUCTION
To understand membrane protein folding, it is important to
explore the nature of the transition state in the folding process.
Φ-value analysis discerns the structure of the transition state by
determining whether individual residues have their native
contacts or not in the transition state.1 Destabilizing point
mutations are introduced by deleting interactions made in the
folded state and the φ-value measures what fraction of the total
destabilization also occurs in the transition state. When φ = 1,
the full destabilization seen in the folded state is also realized in
the transition state, suggesting that the side chain makes the
same interactions in the transition state as in the native state. In
other words, that part of the protein is structured in the
transition state. Alternatively, when φ = 0, it implies that the
mutated side chain has no effect on transition-state stability and
therefore does not have native-like contacts in the transition
state. By measuring φ-values for many residues, it is possible to
map the transition state structure.
Although Φ-value analysis has been used extensively to study
the folding of small water-soluble proteins,2−8 the applications
to membrane proteins have been limited. The Radford and
Brockwell groups obtained extensive φ-values for the coupled
folding/insertion of the β-barrel outer membrane protein
PagP.9 Their results suggest that the protein inserts via a
partially folded structure that is tilted sideways with respect to
the membrane normal. Otzen obtained φ-values for the helical
membrane protein DsbB, suggesting the early formation of
structure near the tips of several transmembrane helices may
nucleate a wave of structure formation.10 Previously, the
mechanism of bR folding has been studied with unfolded
bacterioopsin (bO) as the initial state.11−14 Folding from
unfolded bO involves formation of multiple intermediates and
binding of retinal, which makes the kinetics unsuitable for φ-
value analysis of a single transition state. However, refolding
from unfolded bR (bRU), which still retains retinal, occurs with
a single dominant rate-limiting step and allows investigation of
the transition state by φ-value analysis. Using this approach, the
Booth group obtained φ-values for two helices in bR.15,16 These
results indicated that helix B is structured in the transition state,
forming a nucleus for consolidation of the rest of the protein
structure.
Subsequent to the initial φ-value analyses of bR folding, we
found that the kinetics of bR folding was significantly altered by
bulk solution concentrations of detergent,17 which would likely
confound φ-value measurements. For folding studies of bR, the
protein is commonly solubilized in mixed micelles composed of
a phospholipid (DMPC), a nondenaturing detergent (CHAP-
SO or CHAPS) and various concentrations of the denaturing
detergent SDS to alter the stability of the protein. The native
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bR (bRF) unfolds to SDS-denatured bR (bRU) in a sigmoidal
transition as the concentration of SDS is increased. Similarly,
bRU refolds to bRF as the SDS concentration is decreased. Since
the protein folds within a micelle environment, it is typical to
express SDS concentration as the mole fraction of total
detergent (XSDS). The XSDS can be readily adjusted to unfold
the protein by adding more total SDS or to refold the protein
by adding more total DMPC/CHAPSO or DMPC/CHAPS.
When folding and unfolding kinetic measurements are
performed in this way the bulk detergent concentration
changes, however. Much to our surprise, we found that a
higher DMPC/CHAPSO concentration increases the folding
rate of bR by an unknown mechanism.17 Thus, if one refolds
bR by dilution from high XSDS into low XSDS by simply adding a
high concentration of DMPC/CHAPSO, the folding rate will
increase as XSDS is lowered by both the increased stability of the
folded state and also the higher DMPC/CHAPSO concen-
tration. As a result, the sensitivity of the rate constants with
XSDS will be a complex function of both folding and detergent
properties.
Given the unexpected discovery of the detergent dependence
on folding rates,17 we remeasured a few key φ-values holding
the total DMPC/CHAPSO concentration constant. Our initial
results deviated substantially from the prior measurements. We
therefore repeated and further extended the φ-value analysis to
obtain a more comprehensive view of the transition state for bR
folding.
■ RESULTS AND DISCUSSION
Model for bR Folding Kinetics. Increasing the mole
fraction of SDS results in the conversion of bRF to a bRU state,
which we refer to as unfolding. In the bRu state, tertiary
structure is lost, but most of the secondary structure remains.18
The characteristic absorbance of the retinal cofactor in native
bR serves as a convenient probe to follow this transition in the
protein. Yet the cofactor can also complicate efforts to
investigate the folding of this protein. When bRF is unfolded
to bRU, the retinal Schiff base is susceptible to hydrolysis, which
results in the formation of bacterioopsin (bO). Therefore, the
complete reaction of bR unfolding occurs as shown in Scheme
1, where kf, ku, and kh are the rate constants for folding,
unfolding, and hydrolysis, respectively. Retinal hydrolysis is
reversible but can be treated as irreversible for simplicity in the
range of XSDS where the equilibrium between bRF and bRU is
investigated.17 In this kinetic scheme, the equilibrium between
bRF and bRU can be achieved experimentally only when the
conformational relaxation is much faster than retinal hydrolysis
(ku + kf ≫ kh). We previously demonstrated that bR folding is
significantly faster in 29 mM DMPC and 31 mM CHAPSO
than in 15 mM DMPC and 16 mM CHAPSO (or CHAPS),17
which is the typical condition previously employed for the
investigation of folding energetics of bR.14−16,19,20 Faster
folding of bR in 29 mM DMPC and 31 mM CHAPSO is
beneficial in suppressing the influence of the retinal hydrolysis
on the folding kinetics. However, even in 29 mM DMPC and
31 mM CHAPSO, retinal hydrolysis still interferes with the
folding and unfolding of bR in the transition zone. Therefore,
the hydrolysis reaction must be accounted for as shown in
Scheme 1 in order to determine the rate constants for folding
and unfolding.
When the folding and unfolding of bR occurs as shown in
Scheme 1, the concentration of bRF is expressed as a function
of time in a double-exponential equation:21
= +λ λ− −a e a e[bR ] t tF 1 21 2 (1)
where λ1 and λ2 are the macroscopic rate constants and a1 and
a2 are the amplitudes for the fast phase and the slow phase,
respectively. According to the kinetic model in Scheme 1, λ1
and λ2 are the solutions of the following quadratic equation
(see Supporting Information):21
λ λ− + + + =k k k k k( ) 02 f u h u h (2)
Whether folding or unfolding is monitored, the change in bRF
concentration is described with the same rate constants, λ1 and
λ2. According to the initial conditions, a1 + a2 is zero for a
folding reaction or the initial total bRF concentration for an
unfolding reaction.
On the basis of the property of a quadratic equation, we can
extract the relationship between the macroscopic rate constants,
λ1 and λ2, and the three elementary rate constants for folding,
unfolding, and hydrolysis from eq 2 as follows:
λ λ = k k1 2 u h (3)
λ λ+ = + +k k k1 2 f u h (4)
From these identities, the rate constants for folding and
unfolding under a given condition can be extracted from the
experimentally determined values of λ1, λ2, and kh. The relative
amplitudes of the two phases observed in folding and unfolding
reactions (a1 and a2 in eq 1) are also dependent on kf and ku,
but we did not use the amplitudes in determining kf and ku due
to the limited accuracy with which the amplitudes could be
determined.
Validation of the Kinetic Model. To assess whether the
observed relaxation kinetics are consistent with the kinetic
model (Scheme 1), we first investigated the folding and
unfolding of bR in 29 mM DMPC and 31 mM CHAPSO at
XSDS = 0.73. At this XSDS, bRF shifts instantaneously to a
previously described 600 nm “blue form” before slowly
unfolding to the SDS-denatured state at 440 nm.14 The rapid
shift does not interfere with our kinetic measurements that are
taken over the course of 2 h. The 600 nm “blue form” likely
results from the protonation of D85 and the isomerization of
the retinal cofactor14 which only negligibly alters both the
structure and energetics compared to the unfolding of
bacteriorhodopsin. Data collected at both 560 and 600 nm
gives indistinguishable kinetic rates.
As shown in Figure 1A, refolding features an initial increase
in A600 followed by a slow decay driven by retinal hydrolysis as
expected from our kinetic model. Unfolding also features two
kinetic phases, which is obvious from nonrandom curve fitting
residuals for a single exponential fit (Figure S1). The time scale
of the slow phase is similar to the time scale of retinal
hydrolysis (t1/2 ∼ 10 min),
14,17 suggesting that the biphasic
kinetics result from retinal hydrolysis, consistent with the
model in Scheme 1.
On the basis of this kinetic model, we determined λ1 and λ2
of wild-type bR at varying XSDS using both refolding and
Scheme 1
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unfolding reactions (XSDS = 0.67−0.76) (Figure 1B). When
plotted against XSDS, the natural logarithm of the observed rates
constants (ln λ1 and ln λ2) make a continuous trend throughout
the entire range of XSDS. As predicted by eq 2 (see Supporting
Information), λ1 is greater than kh, and λ2 is less than kh. The
kinetic model predicts that the λ1 and λ2 values observed in the
folding reaction are identical to those observed in the unfolding
reaction at the same XSDS. At XSDS = 0.73, where both folding
and unfolding can be monitored, we found λ1 and λ2 to be (4.5
± 0.3) × 10−3 s−1 and (3.7 ± 0.8) × 10−4 s−1, respectively,
when measured in the folding direction and (3.5 ± 0.3) × 10−3
s−1 and (3.7 ± 0.2) × 10−4 s−1, respectively, when measured in
the unfolding direction (Figure 1B). The similarity in the
kinetic constants is consistent with the model of folding under
the influence of retinal hydrolysis.
Using eqs 3 and 4, we calculated kf and ku values from the
experimentally determined λ1 and λ2 within the transition zone
from the chevron plots shown in Figure 1B. We determined kh
experimentally to be (8.3 ± 0.4) × 10−4 s−1 by monitoring free
retinal release from bRU at XSDS = 0.83 (Figure S2). As seen in
Figure 1C, the ln kf and ln ku values are, within experimental
error, linearly dependent on XSDS in the transition zone of the
equilibrium unfolding curves (XSDS = 0.67−0.76). The values
for kf obtained from unfolding kinetic traces are particularly
unreliable because the error in the kf measurement originates
from both the error in ku and in kh. Consequently, when kf is
small, the absolute errors in both the larger ku and kh values
overwhelm the measurement.
The kinetic model predicts that the kinetic Cm value, where
the kf and ku are equal, should be the same when the values are
obtained from the folding reaction or the refolding reaction.
Indeed, the kinetic Cm value for wild-type bR (the intersection
of the linear fits of ln kf and ln ku) is 0.73 in XSDS when the
values are obtained from refolding experiments and 0.73 in
XSDS when the parameters are obtained by unfolding experi-
ments. Overall, the kinetic scheme fits the observed behavior
well.
Effect of Mutations on Kinetics of bR Folding. To
survey the effect of mutations on the folding kinetics of bR, we
tested 30 mutations of buried residues. For each mutant, we
determined kinetic parameters at a range of XSDS around the
transition zone. The dependence of ln ku and ln kf were
generally well described by linear fits. The mutations L66A,
F71A, D115A, R134A, W138A, S141A, M145A, and L149A did
not destabilize bR more than 0.5 kcal/mol according to our
kinetic measurements and therefore were not suitable for φ-
value analysis. Other mutations appeared to alter the folding
pathway of bR precluding the application of φ-value analysis.
For example, the m‡‑u for the mutants I119A and L93A, T47A
were near zero (Figure S3). Such a drastic change in the
response to denaturant implies an altered folding pathway.
Mutants L94A, W86F, I148A, W189F, and F219A displayed
altered kinetic traces as compared to the wild-type bR (Figure
S4). Specifically, our kinetic model predicts that the irreversible
hydrolysis of retinal in the transition zone of bRF to bRU will
eventually convert all the protein to bO, but these mutants had
a significant residual absorbance that lasted for many hours,
perhaps reflecting residual structure in the unfolded state. In
the end, we chose 16 bR mutants that we considered suitable
for φ-value analysis. An example (L152A bR) is shown in
Figure 1B and 1C, and all the chevron plots are present in
Figure S5. The results from the kinetic analysis of the selected
mutants are summarized in Table 1.
Figure 1. Conformational relaxation kinetics of bR in the folding
transition zone. (A) The refolding of bRU (red) and unfolding of bRF
(blue) monitored at XSDS = 0.73 by the absorbance of the folded
protein at 600 nm (A600). The curve-fitting of the change of A600 with
eq 1 is shown in black lines. (B) Dependence of the observed rate
constants on XSDS. The natural logarithms of the rate constants of the
fast (λ1) and slow (λ2) phases of conformational relaxation of wild-
type (black) and L152A (blue) bR’s are plotted against XSDS. Whether
the values were obtained from unfolding or refolding is indicated in
the figure. The rate of retinal hydrolysis (kh; black line) is plotted for
reference. (C) Dependence of the folding and unfolding rate constants
on XSDS. The natural logarithms of the rate constants for folding (kf)
and for unfolding (ku) of wild-type (black) and L152A (blue) bR’s are
plotted against XSDS. Whether the values were obtained from unfolding
or refolding is indicated in the figure.
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Tanford β Value. The slopes of the plots of ln kf (m‡‑u) and
ln ku (m‡‑n) versus XSDS are measures of the protein’s sensitivity
to denaturant, and reflect how close in their interaction with
SDS the folding transition state is to the folded or unfolded
state on the reaction coordinate. For wild-type bR m‡‑u = −12.8
± 0.7 kcal/mol and m‡‑n = 18.9 ± 0.7 kcal/mol. The slope in
the unfolding direction is larger than the slope in the folding
direction, indicating that the transition state is closer to the
unfolded state. This is generally quantified by the Tanford β-
value:
β =
−
‡‐
‡‐ ‡‐
m
m m
u
u u
We obtain a β-value of 0.4, suggesting that the transition
state for unfolding is a little more than halfway to the fully
unfolded protein. This value contrasts with the previously
determined β-value of 0.1,15 most likely because the slopes
were previously altered by the changing detergent concen-
trations. The previous study also reported that β-values of bR
mutants correlate with the change in the energy of the
transition state (ΔΔG‡‑U), indicating the movement of the
transition state along the reaction coordinate upon destabiliza-
tion of the protein.16 However, we do not observe any
significant correlation either between the β-values and ΔΔG‡‑U
or between the kinetic m-values and ΔΔGunf° (Figure S6). The
lack of the dependence suggests that destabilization of the
native structure by mutations does not alter the degree of the
interaction between the transition state and SDS relative to bRF
and bRU.
Correspondence of Kinetic and Equilibrium Measure-
ments. The ratio of the rate constants ku/kf corresponds to the
equilibrium constant for the bRF to bRU transition, Kunf(bR).
To further validate the model, it would be useful to compare
the equilibrium constant calculated with the rate constants with
the value obtained from equilibrium measurements. Direct
comparison of kinetically inferred equilibrium constants to
experimentally determined equilibrium constants is not
possible, however, because the bRF to bRU transition is not
fast enough to eliminate the interference from retinal
hydrolysis.22 Nevertheless, we can obtain the equilibrium
constant, Kunf(bO), for the overall reaction:
22 bRF ⇌ bO +
retinal. We therefore decided to compare the mutational effects
on Kunf(bO) from equilibrium measurements with their effects
on Kunf(bR) obtained from kinetics. Since linear free energy
relationships do not appear to hold over a large range of XSDS,
23
we wanted to minimize extrapolations. We therefore compare
values at XSDS = 0.67, near the lower edge of the transition zone
for the wild-type protein. Since all the mutants in this work
destabilize the protein, this is a point where we can generally
either make a direct measurement or where only a short
extrapolation is required.
For the mutants used in φ-value analysis, we compared
ΔΔGunf° obtained by kinetics with those obtained from the
equilibrium measurements. As shown in Figure 2, we see a
linear correlation with a slope of 0.97, very close to ideal
expected slope of 1.00. The close agreement despite a
difference in reference state and a large shift in Cm between
the two methods further supports the validity of our kinetic
model.
Φ-Value Analysis of Bacteriorhodopsin. With the
kinetic model that can reliably determine kf and ku for bR,
we set out to map the transition state of folding by φ-value
analysis. Φ-values are the ratio of the change in free energy of
the transition state upon mutation, ΔΔG‡‑U, (derived from kf)
to ΔΔGunf° (here derived from kf and ku). The ideal mutation
for φ-value analysis destabilizes the protein by at least 1 kcal/
mol to provide sufficient signal-to-noise,24 without introducing
any new interactions or altering the kinetic behavior.1 The
mutants for which we have determined φ-values (Table 1) were
selected based on these criteria. Also, for φ-value determination
we used kinetic constants at XSDS = 0.67, which either required
no extrapolation or only small extrapolations from the
experimentally observable range of XSDS.
The 16 reliable φ-values provide good coverage across the
protein (Figure 3). Including the residues that make interhelical
contacts with the mutated residues, this analysis covers the
Table 1. Folding and Unfolding Kinetics of Bacteriorhodopsin and Its Mutants
φF
ΔΔGunf°kina
(kcal/mol)
ΔΔGunf°eqb
(kcal/mol)
m‡‑u
(kcal/mol)
m‡‑f
(kcal/mol)
mkin
c
(kcal/mol)
kf
d
(×10−3 s−1)
ku
d
(×10−3 s−1)
WT − − − −12.8 ± 0.7 18.9 ± 0.7 31.7 ± 0.9 7.8 ± 1.0 0.3 ± 0.03
L13A 0.23 ± 0.06 −1.8 ± 0.2 −1.3 ± 0.1 −15.0 ± 0.7 27.4 ± 1.9 42.3 ± 2.0 3.8 ± 0.3 3.1 ± 0.7
M20A 0.25 ± 0.06 −2.8 ± 0.5 −2.7 ± 0.1 −7.8 ± 0.4 19.2 ± 2.8 27.0 ± 2.8 2.4 ± 0.3 10.8 ± 0.9
F27A 0.43 ± 0.07 −2.1 ± 0.2 −2.2 ± 0.2 −14.1 ± 0.7 17.7 ± 1.3 31.8 ± 1.4 1.7 ± 0.2 2.3 ± 0.6
K41A 0.13 ± 0.12 −0.9 ± 0.2 −0.7 ± 0.1 −12.6 ± 1.2 25.1 ± 0.7 37.7 ± 1.3 6.4 ± 0.8 1.1 ± 0.1
F42A 0.29 ± 0.10 −2.1 ± 0.4 −1.8 ± 0.1 −12.3 ± 1.8 14.4 ± 2.7 26.7 ± 3.3 2.8 ± 0.8 3.7 ± 1.6
T46A 0.26 ± 0.09 −2.2 ± 0.5 −2.3 ± 0.1 −11.2 ± 0.7 12.6 ± 2.2 23.8 ± 2.2 3.0 ± 0.7 4.7 ± 3.5
M60A 0.10 ± 0.14 −1.1 ± 0.3 −1.1 ± 0.1 −17.4 ± 2.1 15.6 ± 3.6 33.0 ± 4.2 6.6 ± 1.4 1.6 ± 0.5
Y83Ae 0.25 ± 0.10 −1.7 ± 0.4 −0.8 ± 0.1 −14.3 ± 0.6 15.6 ± 1.9 29.9 ± 2.0 3.9 ± 0.8 2.4 ± 1.1
L97A 0.26 ± 0.08 −2.9 ± 0.4 −2.4 ± 0.1 −11.2 ± 1.1 33.4 ± 1.3 44.6 ± 1.7 2.2 ± 0.7 12 ± 5
L100A 0.20 ± 0.07 −3.2 ± 0.3 −2.9 ± 0.2 −9.9 ± 1.2 21.2 ± 1.1 31.1 ± 1.6 2.7 ± 0.9 22 ± 8
L111A 0.25 ± 0.07 −2.0 ± 0.3 −1.8 ± 0.1 −10.8 ± 1.7 27.7 ± 1.9 38.4 ± 2.5 3.3 ± 0.6 3.6 ± 1.0
L152A 0.21 ± 0.06 −2.1 ± 0.2 −1.6 ± 0.1 −10.4 ± 1.1 20.1 ± 0.9 31.2 ± 1.4 3.7 ± 0.5 5.2 ± 0.8
F171A 0.23 ± 0.09 −1.1 ± 0.2 −0.9 ± 0.1 −8.7 ± 1.2 21.5 ± 1.5 30.2 ± 1.9 5.1 ± 0.4 1.3 ± 0.1
L174A 0.28 ± 0.16 −1.8 ± 0.4 −1.8 ± 0.1 −12.8 ± 3.9 9.2 ± 3.2 22.0 ± 5.0 3.4 ± 1.4 2.5 ± 1.0
Y185Af 0.29 ± 0.08 −4.2 ± 0.5 −2.9 ± 0.1 −13.6 ± 1.4 23.1 ± 1.8 36.7 ± 2.2 1.0 ± 0.5 47 ± 30
E204A 0.34 ± 0.08 −2.2 ± 0.3 −1.8 ± 0.1 −8.1 ± 0.6 15.8 ± 1.6 24.0 ± 1.7 2.2 ± 0.3 3.4 ± 1.5
aΔΔGunf°kin values were calculated from kf and ku at XSDS = 0.67 using eq 6. bΔΔGunf°eq values are the stability of bR determined with bO as the
reference state. cmkin = m‡‑f − m‡‑u.
dKinetic constants at XSDS = 0.67
eMutation shifted λmax to 520 nm in DMPC/CHAPSO.
fMutation shifted λmax
to 530 nm in DMPC/CHAPSO.
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structure of bR extensively. The mutations that are excluded
from φ-values do not show any apparent pattern in their
distribution on the structure (Figure 3B), which indicates that
our survey is not biased to a specific region by their exclusion.
Every φ-value measured was low. In particular, 14 of the 16 φ-
values measured were at or below 0.3 and the other two (F27A
and E204A) were ∼0.4.
The globally distributed low φ-values indicate that develop-
ment of a localized folding nucleus in the transition state is not
likely. Even the two residues with relatively higher φ-values are
distant from each other in the native structure, unlikely to
coalesce in a folding nucleus. Considering most of the mutated
residues contain extensive interhelical contacts in the native
structure, we can picture that interhelical packing is minimal in
the transition state. These results suggest that there is not a
high degree of unique structure in the transition state.
Mechanism of Folding from SDS-Denatured Bacter-
iorhodopsin. The kinetics of refolding from the bO state has
been investigated in the pioneering spectroscopic studies of the
Booth group12,13,25,26 and more recently by elegant studies by
the Lanyi group27 using EPR methods and the Konermann
group using pulsed oxidation or H/D exchange reactions.28,29
All see a series of intermediate states prior to the slow
incorporation of retinal. In our case, however, we are examining
Figure 2. Comparison of ΔΔGunf°(bR) from kinetics to ΔΔGunf°(bO)
from equilibrium measurements. The effect of mutation on the free
energy of unfolding as measured via the kinetic model to the bRU
reference state or obtained from equilibrium methods to the bO
reference state. A weighted linear fit to the data is shown (slope = 0.97,
intercept = 0.26 kcal/mol, R2 = 0.88).
Figure 3. Φ-value map of bR. (A) The side chains of the 16 positions where we obtained reliable φ-values are shown in purple on the structure of bR
(PDB 1C3W32). The backbone trace is shown as a green ribbon. (B) The side chains of the positions that did not yield usable φ-values are shown in
red, along with the side chains of positions that did yield useable φ-values in purple. (C) The positions are shown on a secondary structure map
below using the same color scheme in panels A and B.
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folding from the bRU state for which the retinal is already
covalently attached. Folding from bRU is less complex and is
well described by a two-state model14,22 as in Scheme 1.
The structure of bRU in SDS has been investigated by the
Lanyi and Langen laboratories using DEER spectroscopy.18
Their results indicate that the transmembrane helix structure
remains, but is heterogeneously frayed, consistent with the
∼40% reduction in helical content seen by far-UV CD
spectroscopy.11 Results from the Konermann group using
pulsed H/D exchange are also consistent with fluctuating
helical secondary structure.29 In contrast, the tertiary structure
is largely lost in the SDS unfolded state. Thus, folding of bR
from an SDS denatured state (bRU) involves the assembly of
largely preformed transmembrane helices as envisioned in the
two-stage model of helical membrane protein folding.30 But
how does this assembly occur?
Globally distributed low φ-values indicate that bR does not
have significant interhelical packing in the transition state. On
the basis of our results, we envision an expanded, poorly
ordered transition state in which partially folded, fluctuating
transmembrane helices have roughly correct orientation/
topology and are ready to coalesce in a cooperative fashion.
This model is similar to the topomer search model proposed
for soluble proteins.31 While achieving an approximately
topologically correct structure at random without any energetic
guidance from native contacts is somewhat improbable, finding
this state would be facilitated by the short loops of bR and the
largely preformed helices. If achieving a topologically correct
structure is the rate-limiting step, the energetic barrier to reach
the transition state would be largely entropic. Reducing the
search space significantly, the short loops and the preformed
helices may decrease the entropic cost to achieve the
topologically correct transition state.
Another structural change we may envision to occur in the
transition state is shedding of SDS molecules. The β-value of
0.4 indicates that interaction with SDS in the transition state is
somewhat distinct from that in the unfolded state. In the bRU
state, SDS is believed to interact with individual helices
extensively. The lack of native-like contacts in the transition
state suggests that some SDS may still remain between helices
in the transition state.
The low fractional φ-values may also result from a number of
relatively iso-energetic pathways. In this case, the transition
state is an ensemble of structures that contain native-like
interhelical contacts at different locations. It is easy to envision
a folding mechanism involving an initial collection of helices as
the transition state followed by the rapid accrual of the
additional helices. Such a mechanism could occur by many
different pathways. To have similar low φ-values throughout
the protein structure, however, each pathway needs to
contribute equally to the overall folding of bR, which is
somewhat hard to imagine considering the cooperative nature
of protein folding in general.
■ CONCLUSIONS
Refolding of bacteriorhodopsin from the SDS-denatured bRU
state offers a valuable opportunity to investigate folding of
helical membrane proteins in a great detail. Though retinal
hydrolysis complicates the kinetics, we demonstrate here that
using a proper kinetic model we can reliably determine folding
and unfolding kinetic parameters. Refolding to bRF followed by
slow retinal hydrolysis allowed us to determine folding and
unfolding kinetic constants simultaneously in an extended
region near the transition zone (Figure 1C), which is not
possible in most proteins. We confirmed the validity of the
kinetic model and the folding and unfolding kinetic constants
from the model by comparing kf and ku determined from
unfolding reactions and those determined from folding
reactions (Figure 1A) and also by comparing ΔΔGunf° values
determined from kinetics with those determined from
equilibrium unfolding.
Our φ-value analysis of the bRU-to-bRF transition indicates
that the structure of the transition state is poorly organized
without any significant interhelical native contacts. This finding
is distinct from the previous report of helix B being the folding
nucleus of bR folding,16 demonstrating the importance of
eliminating the effect of the change in detergent concentrations
on folding rates. With the comprehensive φ-value analysis, bR
is a rather unique membrane protein since we now have
considerable structural information about the folded state,32 the
unfolded state,18 and the transition state. On the basis of the
known structure of bRU and our φ-value analysis, we propose
that the rate-limiting step of bR refolding from SDS-denatured
form is finding the topologically correct helical arrangement
from the ensemble of rapidly interconverting conformations
with largely preformed helices. As the orientation of the
transmembrane helices is limited in a bilayer, bR may not have
this topology search problem under natural conditions. Thus, it
is possible that the folding transition state is different under
native conditions, but investigation of that possibility will
require developing new technology for studying the folding
process in bilayers.23,33
■ EXPERIMENTAL SECTION
Materials. Wild-type and mutant bR’s were expressed and purified
as previously described.34−36 1,2-Dimyristoyl-sn-glycerol-3-phospho-
choline (DMPC) was purchased from Avanti Polar Lipids (Alabaster,
AL). 3[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propane-
sulfonate (CHAPSO) was purchased from Affymetrix (Maumee, OH).
Bio-Xtra sodium dodecyl sulfate was purchased from Sigma-Aldrich.
Refolding Kinetics. The bR protein was equilibrated in 10 mM
sodium phosphate buffer (pH 6.0) containing 15 mM DMPC and 16
mM CHAPSO at 25 °C for at least an hour prior to refolding
experiments. The protein was first unfolded by incubating 1.0 mg/mL
bR in 10 mM sodium phosphate buffer (pH 6.0) containing 15 mM
DMPC/16 mM CHAPSO and SDS at XSDS = 0.82 at room
temperature for 3 min. Refolding was then initiated by diluting 10-
fold into a 10 mM sodium phosphate buffer (pH 6.0) containing
varying concentrations of SDS, DMPC, and CHAPSO at 25 °C. The
final refolding reactions contained 29 mM DMPC, 31 mM CHAPSO
and 0.10 mg/mL bR. The absorption at 600 nm was monitored on a
Molecular Devices Spectra Max M5 plate reader for 2 h. The rate
constants for each refolding reaction were determined by fitting a plot
of the A600 versus time to eq 1. Because folding and unfolding rate
constants are not sensitive to small differences in kh (data not shown),
we assumed kh in the mutants is the same as that of wild-type bR.
Mutants Y83A and Y185A had altered λmax values of 520 and 530 nm,
respectively, when solubilized in DMPC/CHAPSO. The absorption at
560 nm was used to monitor the refolding of these mutants.
Unfolding Kinetics. bR was equilibrated in 10 mM sodium
phosphate buffer (pH 6.0) containing 15 mM DMPC and 16 mM
CHAPSO at 25 °C for at least an hour prior to unfolding. Unfolding
was initiated at 25 °C by a 10-fold dilution into a 10 mM sodium
phosphate buffer (pH 6.0) containing 30 mM DMPC, 32 mM
CHAPSO, and varying concentrations of SDS. The final unfolding
reactions contained 29 mM DMPC and 31 mM CHAPSO. The final
protein concentration was 0.10 mg/mL. The absorption at 600 nm
was monitored on a Molecular Devices Spectra Max M5 plate reader
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for 2 h. Observed rate constants for each unfolding reaction were
determined by fitting a plot of the A600 versus time according to eq 1.
Determination of Consensus Values for the Observed Rate
Constants in the Transition Zone. To ensure accurate determi-
nation of λ1 and λ2 for bR, we measured the kinetic constants for both
folding and unfolding reactions in triplicate within a range of XSDS near
the Cm. We calculated kf and ku from λ1, λ2, and kh using eqs 3 and 4.
For kh, we use (8.3 ± 0.4) × 10
−4 s−1, which we determined by
monitoring free retinal release from wild-type bRU at XSDS = 0.83. We
assumed mutations do not affect kh. To validate this assumption, we
investigated the kinetics of hydrolysis step of two mutants. The kh
values of L111A bR and E204A bR were (7.5 ± 0.2) × 10−4 s−1 and
(7.7 ± 0.6) × 10−4 s−1, respectively, which were not significantly
different from that of wild-type bR, (8.3 ± 0.4) × 10−4 s−1. Moreover,
the use of the individual kh values does not affect the φ-values. The
dependence of the natural logarithm of kf on the XSDS (m‡‑u) and the
natural logarithm of ku on the XSDS (m‡‑f) were determined by fitting
the linear portions of the natural logarithms of the consensus rate
constants for folding and unfolding against the XSDS in the transition
zone.
Calculation of Phi Values. Φ-values are the ratio of the free
energy change of the transition state upon mutation (ΔΔG‡‑U) to the
free energy change of unfolding upon mutation (ΔΔGunf°).
ϕ =
ΔΔ
ΔΔ °
‡‐G
GF
U
unf
ΔΔG‡‑U° is calculated from the wild type and mutant folding rates as
follows:
ΔΔ =‡‐G RT
k
k
ln
(wt)
(mut)
f
f
U
(5)
ΔΔGunf° is calculated from the wild type and mutant folding rates and
unfolding rates as follows:
ΔΔ ° = −G RT
k
k
RT
k
k
ln
(mut)
(mut)
ln
(wt)
(wt)
f
u
f
u
unf
(6)
The ku and kf kinetic rates were calculated from the measured λ1 and
λ2 values as described in the text. The value of ku and kf was
interpolated or extrapolated to XSDS = 0.67 using a weighted linear fit
of ln(ku) or ln(kf) by the predict function in the R statistics program.
These values were then used to calculate the φ-value. The error for the
φ-value was propagated from the triplicate measurement of λ1 and λ2.
The error for the interpolation or extrapolation to XSDS = 0.67 used
the 95% confidence interval for the predicted value.
Unfolding Equilibrium Measurements. The bRF-to-bOU
unfolding equilibrium was measured and calculated as described
previously22 except the conditions were altered to match the
conditions used for the refolding kinetics of bR. The final conditions
were 0.1 mg/mL bR, 30 mM DMPC, 32 mM CHAPSO, 10 mM
sodium phosphate pH 6.0, 9.1 μM all-trans RET and varying SDS
concentrations. After the samples were equilibrated in dark at room
temperature for ∼4 days in a 96-well UV-star microplate (Greiner Bio-
One), the absorbance at 553 nm was measured by SpectraMax M5
plate reader (Molecular Devices). All measurements were done in
triplicate.
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